Case report shows lidocaine provided lasting pain relief in chronic pain syndromes, suggesting potential for broader use.
Background and Objectives It has been found that 5% lidocaine with 7.5% dextrose causes irreversible conduction block in animal studies. Our case report subjects allowed us to observe the efficacy of 5% lidocaine for a prolonged analgesia in vivo . Method After performing a diagnostic nerve block with 1% lidocaine, 5% lidocaine with 7.5% dextrose was injected into three patients with trigeminal neuralgia, post-herpetic occipital neuralgia, and intercostal neuralgia, respectively. The patients were followed for one and a half years. Visual Analog Scale (VAS) scores and the side effects were recorded for each patient. Results One patient received a trigeminal block and one patient received an occipital nerve block. Both patients reported immediate and complete pain relief lasting 14 and 8 months, respectively. One patient, given an intercostal nerve block, received immediate pain relief lasting 5 weeks. None of these patients exhibited any appreciable side effects or complications. Conclusions Our observations suggest that 5% lidocaine may be used safely and effectively for the purpose of prolonged analgesia in selected patients with intractable chronic pain syndromes.
No takes yet. Share an insight, caveat, or question.
Choi et al. (1998) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: